Cargando…
Prediction of advanced colonic neoplasm in symptomatic patients: a scoring system to prioritize colonoscopy (COLONOFIT study)
BACKGROUND: Fast-track colonoscopy to detect patients with colorectal cancer based on high-risk symptoms is associated with low sensitivity and specificity. The aim was to derive a predictive score of advanced colonic neoplasia in symptomatic patients in fast-track programs. METHODS: All patients re...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6659265/ https://www.ncbi.nlm.nih.gov/pubmed/31345180 http://dx.doi.org/10.1186/s12885-019-5926-4 |
_version_ | 1783439100522528768 |
---|---|
author | Fernández-Bañares, Fernando Clèries, Ramon Boadas, Jaume Ribes, Josepa Oliva, Joan Carles Alsius, Antoni Sanz, Xavier Martínez-Bauer, Eva Galter, Sara Pujals, Mar Pujol, Marta del Pozo, Patricia Campo, Rafel |
author_facet | Fernández-Bañares, Fernando Clèries, Ramon Boadas, Jaume Ribes, Josepa Oliva, Joan Carles Alsius, Antoni Sanz, Xavier Martínez-Bauer, Eva Galter, Sara Pujals, Mar Pujol, Marta del Pozo, Patricia Campo, Rafel |
author_sort | Fernández-Bañares, Fernando |
collection | PubMed |
description | BACKGROUND: Fast-track colonoscopy to detect patients with colorectal cancer based on high-risk symptoms is associated with low sensitivity and specificity. The aim was to derive a predictive score of advanced colonic neoplasia in symptomatic patients in fast-track programs. METHODS: All patients referred for fast-track colonoscopy were evaluated. Faecal immunological haemoglobin test (3 samples; positive> 4 μg Hb/g), and a survey to register clinical variables of interest were performed. Colorectal cancer and advanced adenoma were considered as advanced colonic neoplasia. A sample size of 600 and 500 individuals were calculated for each phase 1 and phase 2 of the study, respectively (Phase 1, derivation and Phase 2, validation cohort). A Bayesian logistic regression analysis was used to derive a predictive score. RESULTS: 1495 patients were included. Age (OR, 21), maximum faecal-Hb value (OR, 2.3), and number of positive samples (OR, 28) presented the highest ORs predictive of advanced colonic neoplasia. The additional significant predictive variables adjusted for age and faecal-Hb variables in Phase 1 were previous colonoscopy (last 5 years) and smoking (no, ex/active). With these variables a predictive score of advanced colonic neoplasia was derived. Applied to Phase 2, patients with a Score > 20 had an advanced colonic neoplasia probability of 66% (colorectal cancer, 32%), while those with a Score ≤ 10, a probability of 10% (colorectal cancer, 1%). Prioritizing patients with Score > 10, 49.4% of patients would be referred for fast-track colonoscopy, diagnosing 98.3% of colorectal cancers and 77% of advanced adenomas. CONCLUSIONS: A scoring system was derived and validated to prioritize fast-track colonoscopies according to risk, which was efficient, simple, and robust. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12885-019-5926-4) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-6659265 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-66592652019-08-01 Prediction of advanced colonic neoplasm in symptomatic patients: a scoring system to prioritize colonoscopy (COLONOFIT study) Fernández-Bañares, Fernando Clèries, Ramon Boadas, Jaume Ribes, Josepa Oliva, Joan Carles Alsius, Antoni Sanz, Xavier Martínez-Bauer, Eva Galter, Sara Pujals, Mar Pujol, Marta del Pozo, Patricia Campo, Rafel BMC Cancer Research Article BACKGROUND: Fast-track colonoscopy to detect patients with colorectal cancer based on high-risk symptoms is associated with low sensitivity and specificity. The aim was to derive a predictive score of advanced colonic neoplasia in symptomatic patients in fast-track programs. METHODS: All patients referred for fast-track colonoscopy were evaluated. Faecal immunological haemoglobin test (3 samples; positive> 4 μg Hb/g), and a survey to register clinical variables of interest were performed. Colorectal cancer and advanced adenoma were considered as advanced colonic neoplasia. A sample size of 600 and 500 individuals were calculated for each phase 1 and phase 2 of the study, respectively (Phase 1, derivation and Phase 2, validation cohort). A Bayesian logistic regression analysis was used to derive a predictive score. RESULTS: 1495 patients were included. Age (OR, 21), maximum faecal-Hb value (OR, 2.3), and number of positive samples (OR, 28) presented the highest ORs predictive of advanced colonic neoplasia. The additional significant predictive variables adjusted for age and faecal-Hb variables in Phase 1 were previous colonoscopy (last 5 years) and smoking (no, ex/active). With these variables a predictive score of advanced colonic neoplasia was derived. Applied to Phase 2, patients with a Score > 20 had an advanced colonic neoplasia probability of 66% (colorectal cancer, 32%), while those with a Score ≤ 10, a probability of 10% (colorectal cancer, 1%). Prioritizing patients with Score > 10, 49.4% of patients would be referred for fast-track colonoscopy, diagnosing 98.3% of colorectal cancers and 77% of advanced adenomas. CONCLUSIONS: A scoring system was derived and validated to prioritize fast-track colonoscopies according to risk, which was efficient, simple, and robust. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12885-019-5926-4) contains supplementary material, which is available to authorized users. BioMed Central 2019-07-25 /pmc/articles/PMC6659265/ /pubmed/31345180 http://dx.doi.org/10.1186/s12885-019-5926-4 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Fernández-Bañares, Fernando Clèries, Ramon Boadas, Jaume Ribes, Josepa Oliva, Joan Carles Alsius, Antoni Sanz, Xavier Martínez-Bauer, Eva Galter, Sara Pujals, Mar Pujol, Marta del Pozo, Patricia Campo, Rafel Prediction of advanced colonic neoplasm in symptomatic patients: a scoring system to prioritize colonoscopy (COLONOFIT study) |
title | Prediction of advanced colonic neoplasm in symptomatic patients: a scoring system to prioritize colonoscopy (COLONOFIT study) |
title_full | Prediction of advanced colonic neoplasm in symptomatic patients: a scoring system to prioritize colonoscopy (COLONOFIT study) |
title_fullStr | Prediction of advanced colonic neoplasm in symptomatic patients: a scoring system to prioritize colonoscopy (COLONOFIT study) |
title_full_unstemmed | Prediction of advanced colonic neoplasm in symptomatic patients: a scoring system to prioritize colonoscopy (COLONOFIT study) |
title_short | Prediction of advanced colonic neoplasm in symptomatic patients: a scoring system to prioritize colonoscopy (COLONOFIT study) |
title_sort | prediction of advanced colonic neoplasm in symptomatic patients: a scoring system to prioritize colonoscopy (colonofit study) |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6659265/ https://www.ncbi.nlm.nih.gov/pubmed/31345180 http://dx.doi.org/10.1186/s12885-019-5926-4 |
work_keys_str_mv | AT fernandezbanaresfernando predictionofadvancedcolonicneoplasminsymptomaticpatientsascoringsystemtoprioritizecolonoscopycolonofitstudy AT cleriesramon predictionofadvancedcolonicneoplasminsymptomaticpatientsascoringsystemtoprioritizecolonoscopycolonofitstudy AT boadasjaume predictionofadvancedcolonicneoplasminsymptomaticpatientsascoringsystemtoprioritizecolonoscopycolonofitstudy AT ribesjosepa predictionofadvancedcolonicneoplasminsymptomaticpatientsascoringsystemtoprioritizecolonoscopycolonofitstudy AT olivajoancarles predictionofadvancedcolonicneoplasminsymptomaticpatientsascoringsystemtoprioritizecolonoscopycolonofitstudy AT alsiusantoni predictionofadvancedcolonicneoplasminsymptomaticpatientsascoringsystemtoprioritizecolonoscopycolonofitstudy AT sanzxavier predictionofadvancedcolonicneoplasminsymptomaticpatientsascoringsystemtoprioritizecolonoscopycolonofitstudy AT martinezbauereva predictionofadvancedcolonicneoplasminsymptomaticpatientsascoringsystemtoprioritizecolonoscopycolonofitstudy AT galtersara predictionofadvancedcolonicneoplasminsymptomaticpatientsascoringsystemtoprioritizecolonoscopycolonofitstudy AT pujalsmar predictionofadvancedcolonicneoplasminsymptomaticpatientsascoringsystemtoprioritizecolonoscopycolonofitstudy AT pujolmarta predictionofadvancedcolonicneoplasminsymptomaticpatientsascoringsystemtoprioritizecolonoscopycolonofitstudy AT delpozopatricia predictionofadvancedcolonicneoplasminsymptomaticpatientsascoringsystemtoprioritizecolonoscopycolonofitstudy AT camporafel predictionofadvancedcolonicneoplasminsymptomaticpatientsascoringsystemtoprioritizecolonoscopycolonofitstudy |